Get App
You are Here : Moneycontrol Forum Forum Topics Stocks

Mangalam Drugs

New Member

34 Messages

It is just a retrospective analysis of 14000 odd patients published in Lancet. As of now Lancet lost all credibility as a medical journal for the last few years, it is a politically motivated publication of vested interests for their personal gain, sponsored by fenatical elements. It is a open retrospective analysis ( not Double Blind Randomised Controlled Trial) , were highly moribund(critically serious) patients who are given HCQS or other treatment are compared with mild cases who dose not need any form of treatment ( as control). It is a open study , where examiner can allot patient of his convince to study or control group after selecting them to fit his predetermined plan of results. This study doesn t carry any value. Many such studies have already come and will keep coming down the line, which are sponsored by vested elements, for personal and political gain. More importantly study by ICMR concluded that HCQS is useful in COVID prophylaxis and they have expanded their recommendation to involve all health care workers and front line workers in India for HCQS prophylaxis. Study by ICMR is a new milestone, first of it s kind in the world, which proved HCQS is useful as a prophylactic agent in COVID. It is this study of ICMR is much more important than any class three open retrospective analytical studies done by few individuals for their personal gain.

12.48 AM May 24th
We take the quality of the messages posted on forum as seriously as our articles. Kindly follow our Code of Conduct and refrain from posting any abusive, promotional or gibberish content on forum.


Get your own permanent - nickname

Choose your nickname

Your permanent Nickname can be distinct from your username and no one need know the link between the two.

Follow us on